Gary H. Lyman, MD, MPH

Articles by Gary H. Lyman, MD, MPH

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach

ByScott D. Ramsey, MD, PhD,Gary H. Lyman, MD, MPH

April 16th 2015

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

BySuja S. Rajan, MHA, MS, PhD,William R. Carpenter, MHA, PhD,Sally C. Stearns, PhD,Gary H. Lyman, MD, MPH

February 13th 2013

Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.

Latest Updated Articles

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach
Published: April 16th 2015 | Updated:
Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
Published: February 13th 2013 | Updated:

Gary H. Lyman, MD, MPH

Articles by Gary H. Lyman, MD, MPH

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

Latest Updated Articles

Trending on AJMC

House Republicans Block Vote on ACA Subsidy Extension

ICYMI: Highlights From the 2025 ASPC Congress on CVD Prevention

Higher BMI, IBD Linked to Hidradenitis Suppurativa Risk via Mendelian Randomization

FDA Approves Rucaparib in BRCA-Mutated mCRPC

Phase 1 RNL-186 Shows Promise for Leptomeningeal Metastases: Andrew Brenner, MD, PhD